leadf
logo-loader
AIM:SCLP FRA:SCP OTC:SCNLF

Scancell Holdings PLC

Receive alerts
Market:
AIM
Market Cap:
£177.31 m
Price
21.75 GBX
Change
-2.47%
52 weeks high
29.00
52 weeks low
10.13

In brief

Scancell Holdings PLC is developing novel immunotherapies for the treatment of cancer based on its technology platforms, ImmunoBody®, Moditope® and AvidiMabTM, with four products in multiple cancer indications and development of a vaccine for COVID-19.

Snapshot

  • Developing innovative cancer immunotherapies
  • Four lead products in development
  • Working on a coronavirus vaccine